Literature DB >> 21800468

Cholera, 2010.

.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21800468

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  17 in total

1.  The global burden of cholera.

Authors:  Mohammad Ali; Anna Lena Lopez; Young Ae You; Young Eun Kim; Binod Sah; Brian Maskery; John Clemens
Journal:  Bull World Health Organ       Date:  2012-01-24       Impact factor: 9.408

Review 2.  Immune responses to cholera in children.

Authors:  Daniel T Leung; Fahima Chowdhury; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Expert Rev Anti Infect Ther       Date:  2012-04       Impact factor: 5.091

3.  Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh.

Authors:  Daniel T Leung; Taher Uddin; Peng Xu; Amena Aktar; Russell A Johnson; Mohammad Arif Rahman; Mohammad Murshid Alam; Meagan Kelly Bufano; Grace Eckhoff; Ying Wu-Freeman; Yanan Yu; Tania Sultana; Farhana Khanam; Amit Saha; Fahima Chowdhury; Ashraf I Khan; Richelle C Charles; Regina C Larocque; Jason B Harris; Stephen B Calderwood; Pavol Kovác; Firdausi Qadri; Edward T Ryan
Journal:  Clin Vaccine Immunol       Date:  2013-03-20

4.  Phase variable O antigen biosynthetic genes control expression of the major protective antigen and bacteriophage receptor in Vibrio cholerae O1.

Authors:  Kimberley D Seed; Shah M Faruque; John J Mekalanos; Stephen B Calderwood; Firdausi Qadri; Andrew Camilli
Journal:  PLoS Pathog       Date:  2012-09-13       Impact factor: 6.823

5.  Evaluation of a rapid test for the diagnosis of cholera in the absence of a gold standard.

Authors:  Anne-Laure Page; Kathryn P Alberti; Vital Mondonge; Jean Rauzier; Marie-Laure Quilici; Philippe J Guerin
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

6.  Relationship between Distinct African Cholera Epidemics Revealed via MLVA Haplotyping of 337 Vibrio cholerae Isolates.

Authors:  Sandra Moore; Berthe Miwanda; Adodo Yao Sadji; Hélène Thefenne; Fakhri Jeddi; Stanislas Rebaudet; Hilde de Boeck; Bawimodom Bidjada; Jean-Jacques Depina; Didier Bompangue; Aaron Aruna Abedi; Lamine Koivogui; Sakoba Keita; Eric Garnotel; Pierre-Denis Plisnier; Raymond Ruimy; Nicholas Thomson; Jean-Jacques Muyembe; Renaud Piarroux
Journal:  PLoS Negl Trop Dis       Date:  2015-06-25

7.  Oral Cholera Vaccine Coverage, Barriers to Vaccination, and Adverse Events following Vaccination, Haiti, 2013.

Authors:  Rania A Tohme; Jeannot François; Kathleen Wannemuehler; Preetha Iyengar; Amber Dismer; Paul Adrien; Terri B Hyde; Barbara J Marston; Kashmira Date; Eric Mintz; Mark A Katz
Journal:  Emerg Infect Dis       Date:  2015-06       Impact factor: 6.883

8.  Knowledge of, attitudes toward, and preventive practices relating to cholera and oral cholera vaccine among urban high-risk groups: findings of a cross-sectional study in Dhaka, Bangladesh.

Authors:  Tasnuva Wahed; Sheikh Shah Tanvir Kaukab; Nirod Chandra Saha; Iqbal Ansary Khan; Farhana Khanam; Fahima Chowdhury; Amit Saha; Ashraful Islam Khan; Ashraf Uddin Siddik; Alejandro Cravioto; Firdausi Qadri; Jasim Uddin
Journal:  BMC Public Health       Date:  2013-03-19       Impact factor: 3.295

9.  Local perceptions of cholera and anticipated vaccine acceptance in Katanga province, Democratic Republic of Congo.

Authors:  Sonja Merten; Christian Schaetti; Cele Manianga; Bruno Lapika; Claire-Lise Chaignat; Raymond Hutubessy; Mitchell G Weiss
Journal:  BMC Public Health       Date:  2013-01-22       Impact factor: 3.295

10.  Perceptions of the usefulness of external support to immunization coverage in Chad: an analysis of the GAVI-Alliance cash-based support.

Authors:  Paulo Ferrinho; Mohammed Dramé; Prosper Tumusiime
Journal:  Pan Afr Med J       Date:  2013-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.